Cresset chosen by Victrix for drug-design projects
Victrix CMCC has agreed to use Cresset’s software for its computational chemistry consulting projects. Cresset’s Spark, Forge and Torch software will be used to help Victrix clients carry out structure-based drug-design projects and build predictive 3D SAR models for lead identification.
'Victrix is very pleased to be able to offer our clients access to Cresset's software,' said Adam Kallel, chief strategy officer at Victrix. 'Cresset’s field-based software significantly expands our ability to help clients with programmes that have little or no structural information.'
Robert Scoffin, CEO of Cresset, added: 'We are delighted that Victrix has chosen to use Cresset’s software for its consulting projects. Our field-based approach of using 3D shape and electrostatics to understand molecular function is particularly valuable when there is no information available about the protein target.
'We look forward to Victrix clients experiencing the difference our software will make to their research.'